Back

Nanomotion technology for testing azithromycin susceptibility of Salmonella enterica

Hinnu, M.; Mets, T.; Kerkez, I.; Putrins, M.; Kaldalu, N.; Cathomen, G.; Pla Verge, M.; Cichocka, D.; Sturm, A.; Tenson, T.; ERADIAMR,

2024-09-06 microbiology
10.1101/2024.09.05.611511 bioRxiv
Show abstract

Azithromycin is used to treat invasive salmonellosis, despite conflicting effective concentrations in vitro and in vivo. Resistance of Salmonella enterica to azithromycin is increasing. We demonstrate that nanomotion technology can be used for rapid phenotypic testing of Salmonellas susceptibility to azithromycin. Nanomotion changes under various culture conditions correlated with susceptibility measured by MIC determination, CFU counting, and fluorescent reporter-based estimates of intrabacterial azithromycin accumulation.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.